Abram Scientific


Abram Scientific focuses on precision blood management to improve clinical outcomes through innovative diagnostic solutions. Their flagship product, the CoagCare platform, offers rapid and accurate blood coagulation diagnostics, enhancing patient care in critical situations.

Abram Scientific Logo

Abram Scientific

400 Oyster Point Blvd Suite #110, South San Francisco, CA 94080


What We Do

A portable viscoelastic blood coagulation diagnostic platform that provides rapid and accurate diagnostics for better clinical outcomes.


Digital Health Technologies

Battlefield Resuscitation


Key People

Abhishek Ramkumar

CEO, Founder

LinkedIn

Richard Wiard

VP of Engineering

LinkedIn

Hannah Knotter

Research Scientist

LinkedIn

Noel Herron

R&D Lab Technician

LinkedIn

Mags McInerney

Product Development

LinkedIn

Erika Ammirati

Regulatory

LinkedIn

News & Updates

Abram Scientific CEO Abhishek Ramkumar selected to present at the Emerging Medtech Summit in Dana Point, California on March 21, 2024.

NSF SBIR Phase IIB and TECP Grants

Abram Scientific awarded two NSF SBIR Phase IIB and Technology Enhancement for Commercial Partnerships (TECP) supplemental grants totaling $0.7M.

Seed Financing for CoagCare Development

Abram Scientific raises $2.4M seed financing to complete product development of CoagCare Viscoelastometry (VEM) system.

Abram Scientific secures $1M National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II Grant.

Abram Scientific secures $2.9M US Army medical research grant to deliver a portable viscoelastic, blood coagulation diagnostic platform for covid-19 associated coagulopathy management.